Lixi Li

12PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsApplications in healthEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 15, 2025
Adjuvant Chemotherapy May be Waived for Breast Cancer Nonresponders to Neoadjuvant Chemotherapy: A Population-Based Large Cohort Study.

Lixi Li, Di Zhang, Shuning Liu

|Apr 25, 2025
Prognostic Models for Overall and Disease-Specific Survival in Palate Squamous Cell Carcinoma: Implications for Postoperative Radiotherapy.

Di Zhang, Lixi Li

|Jul 01, 2024
Integrative analyses identified gap junction beta-2 as a prognostic biomarker and therapeutic target for breast cancer.

Di Zhang, Lixi Li, Fei Ma

|Jul 01, 2024
Efficacy and safety of first-line regimens for advanced HER2-positive breast cancer: A Bayesian network meta-analysis.

Lixi Li, Yun Wu, Bo Lan

|Dec 13, 2023
Applications of digital Medicine in oncology: Prospects and challenges.

Hewei Ge, Lixi Li, Di Zhang

|Jun 23, 2023
Risk factors and prognostic models of lymph node metastatic hypopharyngeal squamous cell carcinoma.

Di Zhang, Lixi Li

Pageof 2

Frequent Collaborators

6 joint publications

Fei Ma

3 joint publications

Di Zhang

2 joint publications

Binliang Liu

2 joint publications

Xiuwen Guan